OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
UFL1 ablation in T cells suppresses PD-1 UFMylation to enhance anti-tumor immunity
Chuan He, Xixin Xing, Hsin-Yi Chen, et al.
Molecular Cell (2024) Vol. 84, Iss. 6, pp. 1120-1138.e8
Open Access | Times Cited: 16
Chuan He, Xixin Xing, Hsin-Yi Chen, et al.
Molecular Cell (2024) Vol. 84, Iss. 6, pp. 1120-1138.e8
Open Access | Times Cited: 16
Showing 16 citing articles:
USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy
H. Li, Yishuang Sun, Yingmeng Yao, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 16
Closed Access | Times Cited: 31
H. Li, Yishuang Sun, Yingmeng Yao, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 16
Closed Access | Times Cited: 31
The epitranscriptional factor PCIF1 orchestrates CD8+ T cell ferroptosis and activation to control antitumor immunity
Bolin Xiang, Meiling Zhang, Kai Li, et al.
Nature Immunology (2025) Vol. 26, Iss. 2, pp. 252-264
Closed Access | Times Cited: 2
Bolin Xiang, Meiling Zhang, Kai Li, et al.
Nature Immunology (2025) Vol. 26, Iss. 2, pp. 252-264
Closed Access | Times Cited: 2
PTMs of PD-1/PD-L1 and PROTACs application for improving cancer immunotherapy
Xiaohui Ren, Lijuan Wang, Likun Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Xiaohui Ren, Lijuan Wang, Likun Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
UFMylation: An integral post-translational modification for the regulation of proteostasis and cellular functions
Xiaohui Wang, Xiaowei Lv, Jingjing Ma, et al.
Pharmacology & Therapeutics (2024) Vol. 260, pp. 108680-108680
Closed Access | Times Cited: 4
Xiaohui Wang, Xiaowei Lv, Jingjing Ma, et al.
Pharmacology & Therapeutics (2024) Vol. 260, pp. 108680-108680
Closed Access | Times Cited: 4
UFMylation in tumorigenesis: Mechanistic insights and therapeutic opportunities
Bingtao Liu, Tiantian Yang, Jialin Zhang, et al.
Cellular Signalling (2025), pp. 111657-111657
Closed Access
Bingtao Liu, Tiantian Yang, Jialin Zhang, et al.
Cellular Signalling (2025), pp. 111657-111657
Closed Access
UFMylation of NLRP3 Prevents Its Autophagic Degradation and Facilitates Inflammasome Activation
Jiongjie Jing, Fan Yang, Ke Wang, et al.
Advanced Science (2025)
Open Access
Jiongjie Jing, Fan Yang, Ke Wang, et al.
Advanced Science (2025)
Open Access
UFL1 promotes survival and function of virtual memory CD8 T cells
Brinda Bhatt, Kunal Kumar, Huidong Shi, et al.
The Journal of Immunology (2025)
Closed Access
Brinda Bhatt, Kunal Kumar, Huidong Shi, et al.
The Journal of Immunology (2025)
Closed Access
Mulin Yang, Zhiyang Zhao, Jie Di, et al.
Journal of Clinical Laboratory Analysis (2025)
Open Access
Targeting cTRIP12 counteracts ferroptosis resistance and augments sensitivity to immunotherapy in pancreatic cancer
Hongyi Lin, Shuncang Zhu, Yinghao Chen, et al.
Drug Resistance Updates (2025), pp. 101240-101240
Open Access
Hongyi Lin, Shuncang Zhu, Yinghao Chen, et al.
Drug Resistance Updates (2025), pp. 101240-101240
Open Access
Targeting PD-1 post-translational modifications for improving cancer immunotherapy
Jie Shi, Chuan He, Li Chen, et al.
Cell Insight (2025), pp. 100248-100248
Open Access
Jie Shi, Chuan He, Li Chen, et al.
Cell Insight (2025), pp. 100248-100248
Open Access
Multifaceted roles of UFMylation in health and disease
R. Wang, Li Lin, Jun Zhou, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
R. Wang, Li Lin, Jun Zhou, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Monoclonal antibody immune therapy response instrument for stratification and cost-effective personalized approaches in 3PM-guided pan cancer management
Salem Baldi, Mohammed Alnaggar, Maged AL-Mogahed, et al.
The EPMA Journal (2025)
Closed Access
Salem Baldi, Mohammed Alnaggar, Maged AL-Mogahed, et al.
The EPMA Journal (2025)
Closed Access
The emerging roles of UFMylation in the modulation of immune responses
Zhengyan Liang, Rongxuan Ning, Zhao‐Xiang Wang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 9
Open Access | Times Cited: 3
Zhengyan Liang, Rongxuan Ning, Zhao‐Xiang Wang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 9
Open Access | Times Cited: 3
Role of UFMylation in tumorigenesis and cancer immunotherapy
Lijuan Ding, Xin Jiang, Te Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Lijuan Ding, Xin Jiang, Te Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Panaxatriol exerts anti-senescence effects and alleviates osteoarthritis and cartilage repair fibrosis by targeting UFL1
Biao Kuang, Nana Geng, Yi Miao, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 1
Biao Kuang, Nana Geng, Yi Miao, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 1
UFMylation is involved in serum inflammatory cytokines generation and splenic T cell activation induced by lipopolysaccharide
Sixu Wang, Yuyang Liu, Ming Su, et al.
Cytokine (2024) Vol. 183, pp. 156755-156755
Closed Access
Sixu Wang, Yuyang Liu, Ming Su, et al.
Cytokine (2024) Vol. 183, pp. 156755-156755
Closed Access
Systematic Analysis of UFMylation Family Genes in Tissues of Mice with Metabolic Dysfunction-Associated Steatotic Liver Disease
Mingdi Jiang, Chenlu Zhang, Zhengyao Zhang, et al.
Genes (2024) Vol. 16, Iss. 1, pp. 31-31
Open Access
Mingdi Jiang, Chenlu Zhang, Zhengyao Zhang, et al.
Genes (2024) Vol. 16, Iss. 1, pp. 31-31
Open Access
